US Broker Ratings

Chemed Corp (CHE) Stock Analysis: Evaluating a Healthcare Giant with a Potential 4.71% Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, commands attention with its distinct dual-segment business model and a market capitalization of $5.66 billion. Based in Cincinnati, Ohio,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A High-Stakes Biotech Play with 31.92% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector as a dynamic player with significant growth potential. With a market capitalization of $12.64 billion, this Carlsbad, California-based company..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating the Healthcare Sector with Strong Revenue Growth

As an integral player in the healthcare sector, Medpace Holdings, Inc. (NASDAQ: MEDP) has garnered attention for its robust growth and influential role in the diagnostics and research industry. With..

Legend Biotech Corporation (LEGN) Stock Analysis: A Lucrative 103.96% Upside in the Biotech Space

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its impressive growth potential in the biotechnology sector. As a company at the forefront of developing innovative cell..

Repligen Corporation (RGEN) Stock Analysis: Unpacking a 44% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $6.99 billion, this Massachusetts-based life sciences company..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a Potential 30.92% Upside in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) stands out in the healthcare sector’s dynamic biotech industry, capturing investor attention with a market capitalization of $8.72 billion. This clinical-stage biopharmaceutical company is making significant..

Sanofi (SNY) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Giant

Sanofi (NYSE: SNY), a leading figure in the healthcare sector, offers a compelling investment narrative with a 28.01% potential upside, according to recent analyst ratings. This Paris-based drug manufacturer, with..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a 12.22% Potential Upside Amidst Strong Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector with a market cap of $542.42 billion, remains a focal point for investors seeking stability and growth in the..

Fresenius Medical Care AG (FMS) Stock Analysis: Assessing Growth Potential with a 24% Upside

Fresenius Medical Care AG (NYSE: FMS), a leading global provider of dialysis services and products, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With its headquarters..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Uncharted Waters in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a Hong Kong-based player in the healthcare sector, specifically focusing on the research and commercialization of Traditional Chinese Medicine (TCM) for neurocognitive disorders..

West Pharmaceutical Services (WST): A Healthcare Innovator with an 8.61% Upside Potential

For investors eyeing the healthcare sector, West Pharmaceutical Services, Inc. (NYSE: WST) is a compelling name to consider. With a market capitalization of $22.81 billion, this Exton, Pennsylvania-based company plays..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Tight Market with Strategic Growth Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specializes in medical devices with a focus on life science research and clinical diagnostics. With a market capitalization..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 31.46% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, offers investors an intriguing opportunity in the medical care facilities industry. Based in San Juan Capistrano, California,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 26% Potential Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent name in the biotechnology sector, has caught the attention of investors with its innovative approaches and substantial growth potential. Headquartered in San Diego,..

Baxter International Inc. (BAX) Stock Analysis: Navigating the Healthcare Sector with a 14.71% Potential Upside

Baxter International Inc. (NYSE: BAX) continues to be a significant player in the healthcare sector, offering a comprehensive range of medical instruments and supplies. With a market capitalization of $9.7..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 23% Upside Potential

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, offers a comprehensive portfolio of medical supplies, devices, and diagnostic products. Headquartered in Franklin Lakes, New Jersey, this..

Roivant Sciences Ltd. (ROIV) Stock Report: Analyzing the 30.18% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a pioneering player in the biotechnology sector, is drawing considerable attention from investors. With a market capitalization of $21.57 billion, the company is making waves..

Universal Health Services, Inc. (UHS) Stock Analysis: A 49% Potential Upside Awaits Investors

Universal Health Services, Inc. (NYSE: UHS) offers a compelling investment opportunity for those eyeing the U.S. healthcare sector. Headquartered in King of Prussia, Pennsylvania, UHS operates a network of acute..

Quest Diagnostics (DGX) Investor Outlook: Unveiling a 14.64% Potential Upside

Investors with a keen eye on the healthcare sector should consider Quest Diagnostics Incorporated (NYSE: DGX), a formidable player in the Diagnostics & Research industry. With its headquarters in Secaucus,..

Insulet Corporation (PODD) Stock Analysis: A 68% Potential Upside in the Diabetes Care Market

Insulet Corporation (NASDAQ: PODD) is capturing the attention of investors with its innovative approach to insulin delivery systems, and its current market position suggests a striking potential upside of 68.20%...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds